Sharonov George V, Bocharov Eduard V, Kolosov Peter M, Astapova Maria V, Arseniev Alexander S, Feofanov Alexey V
From the Department of Structural Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of RAS, 117997 Moscow, Russia, the Faculty of Medicine, Moscow State University, 119992 Moscow, Russia.
From the Department of Structural Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of RAS, 117997 Moscow, Russia.
J Biol Chem. 2014 May 23;289(21):14955-64. doi: 10.1074/jbc.M114.558783. Epub 2014 Apr 14.
The EphA2 receptor tyrosine kinase plays a central role in the regulation of cell adhesion and guidance in many human tissues. The activation of EphA2 occurs after proper dimerization/oligomerization in the plasma membrane, which occurs with the participation of extracellular and cytoplasmic domains. Our study revealed that the isolated transmembrane domain (TMD) of EphA2 embedded into the lipid bicelle dimerized via the heptad repeat motif L(535)X3G(539)X2A(542)X3V(546)X2L(549) rather than through the alternative glycine zipper motif A(536)X3G(540)X3G(544) (typical for TMD dimerization in many proteins). To evaluate the significance of TMD interactions for full-length EphA2, we substituted key residues in the heptad repeat motif (HR variant: G539I, A542I, G553I) or in the glycine zipper motif (GZ variant: G540I, G544I) and expressed YFP-tagged EphA2 (WT, HR, and GZ variants) in HEK293T cells. Confocal microscopy revealed a similar distribution of all EphA2-YFP variants in cells. The expression of EphA2-YFP variants and their kinase activity (phosphorylation of Tyr(588) and/or Tyr(594)) and ephrin-A3 binding were analyzed with flow cytometry on a single cell basis. Activation of any EphA2 variant is found to occur even without ephrin stimulation when the EphA2 content in cells is sufficiently high. Ephrin-A3 binding is not affected in mutant variants. Mutations in the TMD have a significant effect on EphA2 activity. Both ligand-dependent and ligand-independent activities are enhanced for the HR variant and reduced for the GZ variant compared with the WT. These findings allow us to suggest TMD dimerization switching between the heptad repeat and glycine zipper motifs, corresponding to inactive and active receptor states, respectively, as a mechanism underlying EphA2 signal transduction.
EphA2受体酪氨酸激酶在许多人体组织的细胞黏附和导向调节中起着核心作用。EphA2的激活发生在质膜中适当的二聚化/寡聚化之后,这一过程在细胞外和细胞质结构域的参与下进行。我们的研究表明,嵌入脂质双分子层中的EphA2分离跨膜结构域(TMD)通过七肽重复基序L(535)X3G(539)X2A(542)X3V(546)X2L(549)发生二聚化,而不是通过许多蛋白质中典型的用于TMD二聚化的替代甘氨酸拉链基序A(536)X3G(540)X3G(544)。为了评估TMD相互作用对全长EphA2的重要性,我们在七肽重复基序(HR变体:G539I、A542I、G553I)或甘氨酸拉链基序(GZ变体:G540I、G544I)中替换关键残基,并在HEK293T细胞中表达带有黄色荧光蛋白标签的EphA2(野生型、HR和GZ变体)。共聚焦显微镜显示所有EphA2-YFP变体在细胞中的分布相似。在单细胞水平上,用流式细胞术分析了EphA2-YFP变体的表达及其激酶活性(酪氨酸(Tyr)(588)和/或酪氨酸(Tyr)(594)的磷酸化)以及与ephrin-A3的结合。当细胞中的EphA2含量足够高时,即使没有ephrin刺激,也能发现任何EphA2变体的激活。突变体变体中ephrin-A3的结合不受影响。TMD中的突变对EphA2活性有显著影响。与野生型相比,HR变体的配体依赖性和非配体依赖性活性均增强,而GZ变体的活性则降低。这些发现使我们能够提出,TMD在七肽重复基序和甘氨酸拉链基序之间的二聚化转换,分别对应于受体的非活性和活性状态,是EphA2信号转导的潜在机制。